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Background: Little is reported about the role of medical management in the treatment of spinal arachnoid diverticula
(SAD) in dogs.
Objectives: To describe the outcome of 96 dogs treated medically or surgically for SAD.
Animals: Ninety-six dogs with SAD.
Methods: Retrospective case series. Medical records were searched for spinal arachnoid diverticula and all dogs with
information on treatment were included. Outcome was assessed with a standardized questionnaire.
Results: Fifty dogs were managed medically and 46 dogs were treated surgically. Dogs that underwent surgery were
signiﬁcantly younger than dogs that received medical management. No other variables, related to clinical presentation, were
signiﬁcantly diﬀerent between both groups of dogs. The median follow-up time was 16 months (1–90 months) in the medi-
cally treated and 23 months (1–94 months) in the surgically treated group. Of the 38 dogs treated surgically with available
long-term follow-up, 82% (n = 31) improved, 3% (n = 1) remained stable and 16% (n = 6) deteriorated after surgery. Of the
37 dogs treated medically with available long-term follow-up, 30% (n = 11) improved, 30% (n = 11) remained stable, and
40% (n = 15) deteriorated. Surgical treatment was more often associated with clinical improvement compared to medical
management (P = .0002).
Conclusions and Clinical Importance: The results of this study suggest that surgical treatment might be superior to medical
treatment in the management of SAD in dogs. Further studies with standardized patient care are warranted.
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Surgical treatment of dogs with compressivemyelopathy caused by a spinal arachnoid diverticu-
lum (SAD) has been described.1–7 Several surgical tech-
niques have the aim of spinal cord decompression and
simultaneous prevention of SAD recurrence.6,7 Little is
reported about the role of medical management for
SAD in dogs. Because the underlying etiology of SAD
formation in dogs is yet unknown, there is no causative
medical treatment available. Medical treatment can con-
sist of combinations of anti-inﬂammatory drugs, medi-
cations that decrease the amount of cerebrospinal ﬂuid
(CSF) production, and supportive physical treatment.
To date, the outcome after medical management for
SAD has been described for 5 dogs.1,8–10 In a previous
study, we described the signalment, clinical and imaging
ﬁndings of 122 dogs with SADs, but did not provide
information regarding treatment options and associated
outcome.11 The primary aim of the present study was
therefore to describe the results of medical and surgical
treatment of SAD in a larger population of dogs. Our
secondary aims were to compare the signalment, clinical
presentation and outcome of dogs that underwent medi-
cal or surgical treatment for SAD. We hypothesized
that the signalment and clinical presentation of dogs
undergoing medical or surgical treatment for SAD
would not diﬀer and that although medical manage-
ment of SAD would be eﬀective for a proportion of
studied dogs, it would be associated with a less success-
ful outcome compared to surgical treatment.
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Materials and Methods
This study was in accordance with the local ethical and welfare
committee guidelines of all participating centers.
Dogs
Medical records and imaging ﬁndings of dogs with a diagnosis
of SAD between January 2000 and March 2012 were retrospec-
tively reviewed. The dogs were diagnosed with SAD at the Centre
of Small Animal Studies, Animal Health Trust, England (n = 41);
Faculty of Veterinary Medicine, Ghent University, Belgium
(n = 40), and the Royal Veterinary College, University of London,
England (n = 15). Only dogs with complete medical records,
including information regarding age at diagnosis, sex, bodyweight,
duration of clinical signs, presenting clinical signs, previous or
concurrent neurological diseases, and treatment were included. For
the purpose of this study, dog breeds with an adult weight of more
than 20 kg were considered large. Diagnosis was achieved by mag-
netic resonance imaging (MRI) in 56 dogs, by CT-myelography in
10 dogs, by myelography in 24 dogs and 6 dogs underwent both
myelography and MRI. The speciﬁc imaging details have been
reported previously.9
Data Collection Regarding Treatment and Follow-Up
Medical records were reviewed concerning information on treat-
ment, complications, and neurological status at time of discharge
and short-term follow-up visit. It was assessed, if there was a dif-
ference between medically versus surgically treated dogs, regarding
their sex, age at onset of signs, breed, bodyweight, duration of
clinical signs, the localization of the SAD, the presenting clinical
signs, the progression of signs, and the presence of a concurrent
neurologic disorder.
Medical treatment was deﬁned as any treatment, which did not
involve surgical intervention. This included dogs receiving medica-
tions to decrease the amount of CSF and analgesics. Some of these
dogs also underwent physical rehabilitation.
Surgically treated dogs underwent either a durotomy, a durec-
tomy, or a marsupialization to drain the accumulated ﬂuid from
the subarachnoid space. All surgical procedures were performed
under general anesthesia and dogs received perioperative pain
management. Surgeries were performed by a board-certiﬁed neu-
rologist or a PhD in orthopedic surgery with 25 years of neurosur-
gical experience.
If available, the results of a short-term follow-up visit between
3–6 weeks (median 4 weeks) after surgery were reviewed.
Information regarding long-term follow-up was obtained using
a standardized questionnaire (Appendix S1). Either the referring vet-
erinarian was contacted by email or telephone, or both the veteri-
nary surgeon and owner were contacted by telephone.
Outcome was categorized into 3 diﬀerent subgroups: improved,
stable and deteriorated. Dogs with an initial improvement and
subsequent deterioration were considered as deteriorated. This
assessment was based on the questionnaire provided by the owner
or referring veterinarian.
Statistical Analysis
A logistic regression model was used to assess, if there were
diﬀerences between the medically and surgically treated dogs
regarding sex, bodyweight, age at onset, age at diagnosis, breed,
duration of signs, localization of the SAD, clinical signs, pro-
gression of signs, and the presence of a concurrent neurologic
disorder. These same variables were also compared between the
improved, stable and deteriorated dogs. Then a logistic
regression model was used to compare the outcome of the medi-
cally versus the surgically treated dogs. Commercially available
software was used for all analyses and signiﬁcance was deﬁned
as P < .05a.
Results
Signalment and Clinical Presentation
Ninety-six dogs were included. Fifty dogs (52%) were
treated medically and 46 (48%) were treated surgically.
Medically Treated Dogs. In the medically treated
group, 38 dogs were male (10 neutered) and 12 dogs (6
neutered) were female. The median age at onset of clini-
cal signs was 45.3 months (mean: 46.2 months) with a
range between 3.5 and 156 months. The median weight
was 16.4 kg (mean: 24.1 kg) ranging between 6.1 and
61.5 kg. Nineteen diﬀerent breeds were included in this
group. The most common breed was the pug (n = 11),
followed by the French bulldog (n = 10) and the Rot-
tweiler (n = 7). Clinical signs had been present for
3 days to 41 months, with a median of 3 months
(mean: 7.3 months). Signs were progressive in 41 dogs
(82%) and non-progressive in 9 dogs (18%). All 50
dogs showed ataxia and 3 dogs additional paresis. Five
dogs had fecal incontinence, 2 urinary incontinence and
in 1 dog fecal and urinary incontinence was present.
Nine of the dogs in this group showed signs of discom-
fort upon palpation of the vertebral column. Nine
dogs (18%) had a concurrent neurologic disorder. Two
dogs had a concurrent intervertebral disk herniation,
3 dogs had vertebral malformations, 2 dogs had other
cystic structures (1 synovial cyst and 1 quadrigeminal
cyst), 1 dog had concurrent myelitis and 1 dog a ﬁbro-
cartilaginous embolism. All concurrent disorders, which
aﬀected the vertebral column, occurred at the same site
as the SAD or in the vertebral segment adjacent to it.
Cervical SADs occurred in 22 dogs (44%), 27 dogs
(54%) had a thoracolumbar SAD, and 1 dog had multi-
ple SADs in the cervical region.
Surgically Treated Dogs. This group consisted of 37
male (13 neutered) and 9 female (4 neutered) dogs. The
youngest dog was 3 months old at time of onset of clin-
ical signs and the oldest 124 months. The median age
was 18 months (mean: 31.3 months). The median body-
weight was 17.4 kg (mean: 20.4 kg), ranging from 1.4
to 49 kg. The pug (n = 6), Rottweiler (n = 4) and West
Highland White Terrier (n = 4) were the most common
breeds in this group. The duration of clinical signs ran-
ged from 1 day to 24 months, with a median of
5 months (mean: 2 months). Signs were progressive in
43 dogs (93%) and nonprogressive in 3 dogs (7%).
Ataxia was present in 45 dogs with additional paresis in
3 dogs, additional urinary incontinence in 1 dog and
additional fecal and urinary incontinence in 2 dogs.
One dog showed only signs of cervical hyperesthesia
without any neurologic deﬁcits. Signs of discomfort
upon palpation of the vertebral column were noted in
10 dogs. Ten dogs (22%) receiving surgical treatment
were diagnosed with a concurrent neurologic disorder.
The most common concurrent disorder diagnosed at
time of diagnosis of the SAD, were vertebral
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malformations, which occurred in 7 dogs, followed by
intervertebral disk herniations in 2 dogs. These occurred
at the same site as the SAD or in the vertebral segment
adjacent to it. One dog had a previous history of a ster-
oid-responsive meningitis-arteritis. Twenty-four (52%)
of the surgically treated dogs had a cervical SAD, 20
dogs (43%) a thoracolumbar SAD and 2 dogs had mul-
tiple SADs in the thoracolumbar area.
Comparison of Signalment and Clinical Presentation in
Medically and Surgically Treated Dogs. When compar-
ing the diﬀerences in clinical presentation between medi-
cally and surgically treated dogs, only the age at onset
of clinical signs was signiﬁcantly diﬀerent, with surgi-
cally treated dogs being younger than dogs that under-
went medical management (P = .028).
Treatment
Medically Treated Dogs. Medical treatment consisted
of administration of prednisone in 44 dogs. When
dosages were available from the medical records, they
ranged from 0.3 to 1 mg/kg/d (median 0.65 mg/kg/d).
Physical treatment without any further medical treat-
ment was performed in 3 dogs and carprofen at
2 mg/kg twice daily was used in 2 dogs and gabapen-
tin at 10 mg/kg 3 times daily in 1 dog. Three dogs
underwent physical rehabilitation in addition to their
medical treatment.
Surgically Treated Dogs. The surgical treated dogs
underwent one of several surgical techniques, which
were chosen based on the surgeons’ preference.
Twenty-eight dogs underwent a durectomy with
removal of the arachnoid adhesions, 15 a durotomy,
and 3 a marsupialization. The mean duration of hos-
pitalization was 5.7 days with a median of 5 days.
One dog suﬀered from a major perioperative compli-
cation. This dog underwent a durectomy at C2-3
and experienced postoperative hypoventilation
12 hours after surgery, which made ventilatory sup-
port necessary. Imaging showed formation of a com-
pressive hematoma, which was surgically removed.
The dog required ventilation for 7 days after revi-
sion surgery and was discharged 9 days after the sec-
ond surgery. Minor surgical complications included
severe blood loss, requiring a blood transfusion in 1
dog, early postoperative transient neurologic deterio-
ration in 22 dogs and urinary tract infections
reported in 4 dogs.
Outcome
Medically Treated Dogs. Follow-up information was
available for 37 of the 50 dogs (74%) in this group. A
median follow-up of 16 months (range 1–90 months)
was available. At the time of data collection 15 dogs
(40%) were still alive, 16 dogs (43%) were euthanized
as a consequence of the SAD and 6 dogs (17%) died or
were euthanized due to reasons unrelated to SAD.
Dogs, which were euthanized as a consequence of the
SAD had a mean survival of 15.2 months after diagno-
sis (median 14 months). Seven of these dogs were
diagnosed with a cervical and 9 dogs with a thora-
columbar SAD.
Eleven of the 37 medically treated dogs improved
(30%), 11 remained stable (30%) and 15 deteriorated
(40%). Eight of 31 dogs (26%) treated with prednisone
with known outcome improved, 9 remained stable
(29%) and 14 deteriorated (45%).
Surgically Treated Dogs. Follow-up information was
available for 38 of the 46 surgically treated dogs (83%).
Twenty-ﬁve of these dogs (66%) were alive at the time
of data collection, 5 dogs (13%) were euthanized due to
SAD and 4 dogs (11%) had died or had been eutha-
nized due to an unrelated cause. Euthanasia due to the
SAD was performed mean 12 months after surgery
(median 13 months). Three of the euthanized dogs
underwent surgery for a thoracolumbar SAD and 2 had
a cervical SAD.
Thirty-one dogs improved (82%), 1 remained stable
(3%) and 6 dogs deteriorated (15%).
One dog made an initial improvement and deterio-
rated 9 months after surgery. Magnetic resonance imag-
ing was performed and revealed a laminectomy
membrane formation, which was surgically removed
and lead to a good recovery conﬁrmed by telephone
interview with the owners 24 months after the second
surgery. The dog was ambulatory with mild residual
ataxia at this time.
Comparison of Follow-Up Time and Outcome in Medi-
cally and Surgically Treated Dogs. A median follow-up
time of 16 months (range 1–90 months) was available
for the medically treated dogs and 23 months of follow-
up for the surgically treated cases. This diﬀerence was
not signiﬁcant (P = 0.64).
In the medically treated group signiﬁcantly more dogs
deteriorated. Likewise, there were signiﬁcantly more
surgically treated dogs in the improved group
(P = .0002).
There was no signiﬁcant diﬀerence in outcome for
cervical versus thoracolumbar SADs (P = .65) or large
versus small dog breeds (P = .18).
Discussion
The present study retrospectively described and com-
pared diﬀerent treatment options for dogs with SADs.
Since 1968, 20 reports about treatment of SADs in dogs
are published, with 5 dogs medically treated.1,8–10,12
This study reported the clinical presentation of 50 and
outcome of 37 dogs treated medically for SADs.
To compare medically and surgically treated dogs as
objectively as possible, signalment, clinical signs, pro-
gression of signs, and the presence of concurrent neuro-
logic disorders were assessed and compared between
both treatment groups. The medically and surgically
treated groups diﬀered only signiﬁcantly in the age at
onset of clinical signs with younger dogs undergoing
surgical treatment more often. This diﬀerence might be
explained by the fact that owners are more willing to pur-
sue surgical, cost-intensive treatment in younger dogs.
In both treatment groups, the localization of the
SADs was almost evenly distributed between cervical
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and thoracolumbar sites. There was no diﬀerence in
outcome depending on the localization.
Prednisone was administered to 44 dogs in the medi-
cally treated group and this treatment for SADs has
been described previously.1,8 Prednisone reportedly
decreases the production of CSF and increases its
absorption in addition to its anti-inﬂammatory proper-
ties and eﬀects on vasogenic edema. However, other
studies using prednisolone did not demonstrate a
decrease in CSF pressure.13 Despite the lack of clear
evidence, prednisone is used widely to treat dogs with
ﬂuid accumulation in the subarachnoid space. The eﬃ-
cacy of this treatment in dogs has not been clinically
studied and is based on empiric observations. Of the
dogs treated with prednisone, only 26% improved with
a median follow-up of 24 months. Of the 2 previously
reported cases, which were treated medically, 1
improved and had a follow-up of 1 year.8 The other
dog remained stable over a period of 21 months.1
Other medications used in this study for medical
treatment included nonsteroidal anti-inﬂammatory med-
ications. There has been no report of their use in dogs
with SADs. Their use in SADs might be warranted in
dogs with spinal hyperesthesia, as they have an anal-
gesic eﬀect. Some dogs were treated with gabapentin,
which has been recommended for the treatment of neu-
ropathic pain in dogs with syringohydromyelia.14 In the
present study, only 1 dog was treated with gabapentin,
which makes conclusions about its eﬃcacy in SAD
treatment impossible.
Diﬀerent surgical techniques were used in this study
depending on surgeon’s preference. Durotomy and
durectomy were most commonly performed. These tech-
niques have been described previously in the treatment
of SADs.1,4 Durectomy and marsupialization have been
suggested to represent better treatment options because
of their increased likelihood of permanent drainage of
the subarachnoid space.1,7
Our ﬁnding that a durotomy might be a valid treat-
ment option is diﬃcult to compare to ﬁndings in human
patients. Subarachnoid cysts in people are usually better
demarcated and can often be completely removed.15,16
The space occupying lesion in the subarachnoid space
in people causes compression of the spinal cord, which
leads to neurologic signs. In cases where the cysts are
more widespread and are non resectable, fenestration of
the cyst has been described.17–19 These techniques are
comparable to durotomies or durectomies. However,
durectomies or marsupializations without closure of the
subarachnoid space are uncommonly performed in peo-
ple due to the occurrence of orthostatic headaches asso-
ciated with uncontrolled CSF leakage and the higher
rate of recurrence of the cyst.20,21 Therefore, surgical
management in people aims toward cyst removal and
seems to achieve better outcomes with subsequent clo-
sure of the subarachnoid space.20 Other proposed surgi-
cal techniques in human medicine include shunt
placement to permanently drain the intraarachnoid
diverticulum in a controlled manner.20 In dogs, the
occurrence of orthostatic headaches is probably less
likely due to the quadrupedal gait. However, there
might be a number of undiagnosed orthostatic head-
aches in dogs due to the diﬃculty in diagnosing head-
aches in animals.22
When comparing the outcome between the medically
and surgically treated dogs, signiﬁcantly more dogs
improved in the surgically treated group. This supports
previous reports, which suggest surgery as the treatment
of choice in canine SAD.1,6,7 Spinal arachnoid divertic-
ula cause slowly progressive clinical signs, most likely
by slow growth of the diverticulum. Medications such
as prednisone work through decreasing possible sec-
ondary inﬂammation and edema, although this does not
lead to a long-lasting relief of clinical signs. The inﬂu-
ence of prednisolone on CSF production might decrease
the accumulation of ﬂuid in the SAD. However, in this
study, corticosteroid treatment has an inferior outcome
compared to surgical treatment.
Although the results of this study indicate that surgi-
cal intervention might be superior to medical manage-
ment for dogs with SAD, surgery is more invasive and
pet owners might be hesitant to pursue this route due
to ﬁnancial concerns and concerns about postoperative
deterioration and care.
Recurrence of SAD formation has been reported as
an important long-term complication after surgery.
However, in our study, only one of the dogs had a
relapse and was diagnosed with a laminectomy mem-
brane as the cause of deterioration. It is therefore possi-
ble that not all dogs with recurrence of clinical signs
have recurrence of SAD formation and that the recog-
nition of other complications might be underestimated.
The outcome in this study was purely based on clinical
signs and the long-term follow-up was subjectively
assessed by the owner or the referring veterinarian.
This study was obviously limited by its retrospective
nature, which limited standardization of assessment and
veterinary care. The outcome was assessed using a ques-
tionnaire, but no follow-up visits were conducted. Mul-
tiple institutions from diﬀerent countries were involved,
which could have aﬀected the choice between medical
and surgical management. Most dogs presented to refer-
ral centers in the UK have medical insurance, while this
practice is not common in Belgium. It is therefore possi-
ble, that ﬁnancial reasons were an unrecognized con-
founding variable in this population of dogs. It is also
possible, that other factors, such as the presence of
incontinence or the severity of clinical signs, biased the
decision for medical or surgical treatment.
Although several of these limitations could have been
avoided by a prospective study design, retrospective
studies have the advantage of including a larger number
of animals, which is of major importance in a relatively
rare disease such as SAD.
In summary, this study compared a relatively large
number of medically and surgically treated dogs with
SAD. It supports the previous suggestion that surgical
treatment is a good treatment option for dogs with SAD.
Due to the retrospective nature of this study, it is not
possible to know, whether surgery is truly the superior
option and which surgical technique is preferable. These
questions warrant further prospective investigation.
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